Literature DB >> 2550372

Sera of children with renal tumours contain low-molecular-mass hyaluronic acid.

S Kumar1, D C West, J M Ponting, H R Gattamaneni.   

Abstract

The molecular mass of hyaluronic acid (HA) rather than its serum concentration alone may be a hallmark of certain types of malignancy. A radiometric assay was used to measure HA levels in 35 children with renal tumours [33 Wilms' tumours and 2 bone metastasizing renal tumours of childhood (BMRTC)] and 20 normal siblings of children with cancer. The HA level in the sera of normal children was barely detectable and had a molecular mass of 1-5 x 10(5). In both Wilms' and BMRTC patients, very high levels of HA were found in preoperative serum samples; these fell dramatically following surgical excision of the tumours. A novel finding of our study was the presence of low-molecular-mass HA (similar to the angiogenic fragments of HA) in the sera of BMRTC patients. In contrast, high-molecular-mass HA (which is not angiogenic) was found in the sera of Wilms' patients (2 x 10(6) kDa). Following surgery in BMRTC patients, not only did serum HA levels fall to a value within normal ranges, but also the HA which remained was of high molecular mass.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2550372     DOI: 10.1002/ijc.2910440311

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  16 in total

Review 1.  Hyaluronic acid-based nanocarriers for intracellular targeting: interfacial interactions with proteins in cancer.

Authors:  Ki Young Choi; Gurusamy Saravanakumar; Jae Hyung Park; Kinam Park
Journal:  Colloids Surf B Biointerfaces       Date:  2011-10-20       Impact factor: 5.268

2.  Hyaluronan is not elevated in urine or serum in Hutchinson-Gilford Progeria Syndrome.

Authors:  Leslie B Gordon; Ingrid A Harten; Anthony Calabro; Geetha Sugumaran; Antonei B Csoka; W Ted Brown; Vincent Hascall; Bryan P Toole
Journal:  Hum Genet       Date:  2003-05-01       Impact factor: 4.132

Review 3.  Tumor-associated hyaluronan. Providing an extracellular matrix that facilitates invasion.

Authors:  W Knudson
Journal:  Am J Pathol       Date:  1996-06       Impact factor: 4.307

4.  Registration of the extracellular matrix components constituting the fibroblastic focus in idiopathic pulmonary fibrosis.

Authors:  Jeremy Herrera; Colleen Forster; Thomas Pengo; Angeles Montero; Joe Swift; Martin A Schwartz; Craig A Henke; Peter B Bitterman
Journal:  JCI Insight       Date:  2019-01-10

5.  Circulating hyaluronan, chondroitin sulphate and dextran sulphate bind to a liver receptor that does not recognize heparin.

Authors:  S Gustafson; T Björkman
Journal:  Glycoconj J       Date:  1997-08       Impact factor: 2.916

6.  Development of a novel metastatic breast cancer score based on hyaluronic acid metabolism.

Authors:  Hatem A El-Mezayen; El-Shahat A Toson; Hossam Darwish; Fatheya M Metwally
Journal:  Med Oncol       Date:  2012-12-30       Impact factor: 3.064

7.  Involvement of hyaluronidases in colorectal cancer.

Authors:  Helen Bouga; Isidoros Tsouros; Dimitrios Bounias; Dora Kyriakopoulou; Michael S Stavropoulos; Nikoletta Papageorgakopoulou; Dimitrios A Theocharis; Demitrios H Vynios
Journal:  BMC Cancer       Date:  2010-09-17       Impact factor: 4.430

Review 8.  Role of hyaluronan in glioma invasion.

Authors:  Jong Bae Park; Hee-Jin Kwak; Seung-Hoon Lee
Journal:  Cell Adh Migr       Date:  2008-07-21       Impact factor: 3.405

Review 9.  Hyaluronan and hyaluronidase in genitourinary tumors.

Authors:  Melanie A Simpson; Vinata B Lokeshwar
Journal:  Front Biosci       Date:  2008-05-01

Review 10.  Targeting hyaluronic acid family for cancer chemoprevention and therapy.

Authors:  Vinata B Lokeshwar; Summan Mirza; Andre Jordan
Journal:  Adv Cancer Res       Date:  2014       Impact factor: 6.242

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.